MANGROVE PARTNERS IM, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MANGROVE PARTNERS IM, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2021$1,944,000
+0.3%
200,0000.0%0.12%
-33.5%
Q3 2021$1,938,000
+0.2%
200,0000.0%0.17%
-13.1%
Q2 2021$1,934,000–200,000–0.20%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders